Search Results

A Single-Blind Placebo Run-In Study of Venlafaxine XR for Activity-Limiting Osteoarthritis Pain

Authors: Sullivan, Mark; Bentley, Susan; Fan, Ming-Yu; Gardner, Greg

Source: Pain Medicine, Volume 10, Number 5, July/August 2009 , pp. 806-812(7)

Publisher: Blackwell Publishing

Spotlight on Bupropion in Major Depressive Disorder

Authors: Dhillon, Sohita; Yang, Lily P.H.; Curran, Monique P.

Source: CNS Drugs, Volume 22, Number 7, 2008 , pp. 613-617(5)

Publisher: Adis International

Venlafaxine extended release in pediatric anxiety and depression

Authors: Miller, Leslie; Riddle, Mark A

Source: Pediatric Health, Volume 2, Number 3, June 2008 , pp. 279-288(10)

Publisher: Future Medicine

Bupropion: A Review of its Use in the Management of Major Depressive Disorder

Authors: Dhillon, Sohita; Yang, Lily P.H.; Curran, Monique P.

Source: Drugs, Volume 68, Number 5, 2008 , pp. 653-689(37)

Publisher: Adis International

The cost-utility of maintenance treatment with venlafaxine in patients with recurrent major depressive disorder

Authors: Sobocki, P.; Ekman, M.; Ovanfors, A.; Khandker, R.; Jönsson, B.

Source: International Journal of Clinical Practice, Volume 62, Number 4, April 2008 , pp. 623-632(10)

Publisher: Blackwell Publishing

Duloxetine: A Review of its Use in the Treatment of Major Depressive Disorder

Authors: Frampton, James E.; Plosker, Greg L.

Source: CNS Drugs, Volume 21, Number 7, 2007 , pp. 581-609(29)

Publisher: Adis International

Extended-release formulation of venlafaxine in the treatment of post-traumatic stress disorder

Authors: Pae, Chi-Un; Lim, Hyun-Kook; Ajwani, Neena; Lee, Chul; Patkar, Ashwin A

Source: Expert Review of Neurotherapeutics, Volume 7, Number 6, June 2007 , pp. 603-615(13)

Publisher: Expert Reviews

Duloxetine and venlafaxine XR comparable for GAD

Source: Inpharma, Volume 1, Number 1587, 2007-05-12 , pp. 18-18(1)

Publisher: Adis International

A randomized, double-blind, placebo-controlled study of venlafaxine XR in out-patients with tension-type headache

Authors: Zissis, NP; Harmoussi, S; Vlaikidis, N; Mitsikostas, D; Thomaidis, T; Georgiadis, G; Karageorgiou, K

Source: Cephalalgia, Volume 27, Number 4, April 2007 , pp. 315-324(10)

Publisher: Blackwell Publishing

Escitalopram in the treatment of major depressive disorder: clinical efficacy, tolerability and cost-effectiveness vs. venlafaxine extended-release formulation

Authors: Llorca, P. M.; Fernandez, J.-L.

Source: International Journal of Clinical Practice, Volume 61, Number 4, April 2007 , pp. 702-710(9)

Publisher: Blackwell Publishing

Using meta-regression in performing indirect-comparisons: comparing escitalopram with venlafaxine XR

Authors: Eckert, Laurent; Falissard, Bruno

Source: Current Medical Research and Opinion, Volume 22, Number 11, November 2006 , pp. 2313-2321(9)

Publisher: Informa Healthcare

Remission, dropouts, and adverse drug reaction rates in major depressive disorder: a meta-analysis of head-to-head trials

Authors: Machado, Márcio; Iskedjian, Michael; Ruiz, Inés; Einarson, Thomas R.

Source: Current Medical Research and Opinion, Volume 22, Number 9, September 2006 , pp. 1825-1837(13)

Publisher: Informa Healthcare

Venlafaxine XR PREVENTs the recurrence of depression

Source: Inpharma, Volume 1, Number 1548, 2006-07-29 , pp. 11-12(2)

Publisher: Adis International

Comparison of venlafaxine extended release versus paroxetine for treatment of patients with generalized anxiety disorder

Authors: KIM, TAE-SUK; PAE, CHI-UN; YOON, SU-JUNG; BAHK, WON-MYONG; JUN, TAE-YOUN; RHEE, WON-IHL; CHAE, JEONG-HO

Source: Psychiatry and Clinical Neurosciences, Volume 60, Number 3, June 2006 , pp. 347-351(5)

Publisher: Blackwell Publishing

The mirtazapine orally disintegrating tablet (ODT) has a faster onset of action than extended-release (XR) venlafaxine

Source: Inpharma, Volume 1, Number 1532, 2006-04-08 , pp. 13-13(1)

Publisher: Adis International

Treatment of anxiety disorders with venlafaxine XR

Author: Thase, Michael E

Source: Expert Review of Neurotherapeutics, Volume 6, Number 3, March 2006 , pp. 269-282(14)

Publisher: Expert Reviews

Estimation of symptom-free days in generalized anxiety disorder

Authors: Wan, George J.; Zhang, Huabin F.; Tedeschi, Michael A.; Hackett, David

Source: Current Medical Research and Opinion, Volume 22, Number 3, March 2006 , pp. 587-591(5)

Publisher: Informa Healthcare

Spotlight on Escitalopram in the Management of Major Depressive Disorder

Authors: Murdoch, David; Keam, Susan J.

Source: CNS Drugs, Volume 20, Number 2, 2006 , pp. 167-170(4)

Publisher: Adis International

Assessment of Canadian provincial expenditures in depressed patients treated with venlafaxine XR versus SSRIs: the APEX Study

Authors: Monfared, A. A. Tahami; Han, D.; Sheehy, O.; Bexton, B.; LeLorier, J.

Source: Current Medical Research and Opinion, Volume 22, Number 1, January 2006 , pp. 83-94(12)

Publisher: Informa Healthcare

Escitalopram: A Review of its Use in the Management of Major Depressive Disorder

Authors: Murdoch, David; Keam, Susan J.

Source: Drugs, Volume 65, Number 16, 2005 , pp. 2379-2404(26)

Publisher: Adis International